Dr. Francis Sridhar Katumalla

• Dr. Francis Sridhar Katumalla is a Urologist, Andrologist & Kidney Transplant Surgeon and has an experience in this field.

• He is working as a  Consultant in Urologist, Andrologist & Kidney Transplant Surgeon at KIMS Hospital,Hyderabad

• His specialization includes Urologist, Andrologist & Kidney Transplant .

• He is a member of Medical Council of India. #19986.

• He is a member of Tamil Nadu And Pondicherry Society of Urologists (TAPASU).

• He is a member of South Zone – Urological Society of India (SZ USI) # SZAP F001.

• He is a member of Urological Society of India (USI) # K 166.

• He is a member of American Urological Association (AUA) # ID 00825951.

• He has got Vipin Khanna Gold Medal for Best Intern of 1998.

• He has got Prof. C.L. Ashok Kumar Medal Best Poster Prize. SZ – USICON 2005.

• He has got International Travel fellowship to BAUS Manchester 2010.

• He has got First prize in Radiology Quiz. SZ – USICON 2010.

• He has got Shri Shalivahan Singh Rawal Gold Medal for the best outgoing urology resident 2011 from Christian Medical College, Vellore

• He has got Prof. A Rajasekaran Gold Medal in MCh Urology for the year 2011 by the Dr. MGR Medical University, Tamil Nadu. (This Medal is awarded to the Resident who secures the highest marks in University).

• He has got “Upcoming Young Urologist from India”, jointly by the Urological Society of India and the European Urological Society, in March 2013.

• He has done research on a study of the pattern and mortality outcome of trauma in adults using TRISS Methodology.

• He has done research on a Study to assess the role of second resection in T1G3 bladder tumor.

• He has done research on a prospective study of the co-relation between clinical outcome and residual prostatic volume after TURP for BPH.

• He has done research on Role of Tamsulosin as medical expulsion therapy for ureteric calculus – A prospective study.

• He has done research on a prospective study to evaluate the efficacy of Alpha 1a blocker (Tamsulosin) and PDE5 inhibitor (Tadalafil) used as combination or monotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.

• He has done research on a prospective randomised and comparative study of efficacy and short term outcome of optical internal urethrotomy as monotherapy versus optical internal urethrotomy and intralesional injection of Tri-Inject (Triamcinolone, Mitomycin C, Hyaluronidase) in the treatment of anterior urethral strictures.

• He has done research on a study on prevalence of metabolic syndrome in BPH.

• He has done research on a clinical study on renal infection.

• He has done research on Impact of surgical intervention on renal function in patients with urolithiasis and altered renal parameters.

• He has done research on Bilateral urinoma due to an unilateral impacted ureteral calculus.

• He has done research on Second transurethral resection in T1G3 bladder tumors – Selectively avoidable.

• He has done research on Lower urinary tract symptoms and prostatic calculi: A rare presentation of alkaptonuria.

• He has done research on NON–AIDS defining malignancies: Is transitional cell carcinoma bladder one of them.

• He has done research on Angioembolization for post traumatic renal arteriovenous malformations.